Yourfirst consultation is the most important first step. A registered medical practitioner will give you a basic outline of the entire fertility journey at Asiri Nova IVF, while a board-certified sub fertility specialist will consult and preform a fertility scan to decide on further proceedings.
A coordinator at the Centre will walk you through the state of art facilities and explain any details related to the consents required from you. Free financial counseling will be arranged for you, should you require it.
Carry any relevant medical reports and proof of identification for you and your spouse.
The primary distinction between IUI and IVF lies in the location where fertilization occurs. In the case of IUI, fertilization takes place internally, as the sperm is directly injected into the womans uterus. Consequently, if successful, the resulting embryo implants within the uterus.
In the case of IVF, fertilization is external, occurring outside the uterus within a laboratory setting. Oocytes are extracted from the ovaries after a stimulation process and fertilized with sperm in a laboratory. If fertilization is successful, the embryo is inserted into the uterine cavity. Pregnancy can usually be confirmed in a week.
IVF was originally developed for women with blocked tubes or missing fallopian tubes. IVF is also used when other conditions such as endometriosis or male infertility is present.
Our experts will review your history and guide you to the most appropriate treatment and diagnostic procedures.
Women are born with approximately 2 million eggs in their ovaries. Before a girl reaches puberty, about 11,000 eggs die every month. Thus, in her teenage years, a woman has about 300,000 to 400,000 eggs available. From this point onwards, about 1000 eggs are utilised every month. This has nothing to do with any form of birth control, pregnancy, hormone production, health, lifestyle or nutritional supplements. Eventually, a woman reaches menopause when she has no viable eggs left.
PCOS (Polycystic Ovarian Syndrome) refers to a condition caused by hormonal imbalances. Women suffering from PCOS produce higher than normal amounts of male hormones. This affects ovulation and can result in irregular periods. In some cases, women suffering from PCOS may have irregular periods. This, in turn, can make it harder for these women to conceive. In fact, PCOS is one of the most common causes of female infertility.
Endometriosis is a common disorder found in women, where the endometrial tissues grow outside the uterus. This gynaecological condition can occur in the ovaries, fallopian tubes, the tissues lining the pelvis, and in rare cases, abdominal cavity, too.
Cryopreservation is the process of freezing eggs, sperm or embryos to sub-zero temperatures for later use. When the eggs, sperm or embryos are needed, they are thawed and fertilized or used in a fertility treatment cycle. Sperm may be used for intrauterine insemination (IUI) or in vitro fertilization (IVF) procedures.
It is important to recognize that the rate of birth defects in humans in the general population is about 3% of all births for major malformations and 6% if minor defects are included. Fortunately, 20-plus years following Louise Browns birth (the first IVF baby), we now have ample data that children conceived through IVF have no increase in these rates of birth defects due to the technique itself.
A minor rise in abnormalities is ascribed to the infertility and age factor of the intending parents. Further follow-up on older children indicates that IVF children have done as well or better than their peers in academic achievement (probably a social bias) and have no higher rates of behavioural or psychological difficulties.
PGT-A is genetic testing performed on embryos to identify numerical chromosomal abnormalities or aneuploidy. This test is performed on embryos prior to transfer into the uterus. By analysing all embryos generated in an IVF treatment cycle, those free of chromosomal aneuploidy can be identified for selective transfer. As a result, the pregnancy rates per transfer are increased and the miscarriage rates decreased.
PGT-M involves testing of embryos for specific monogenic disorders like thalassemia, haemophilia and certain types of muscular dystrophy. It helps couples who have a family history or those who have had a child affected with these disorders to have an unaffected child.
All embryos formed as a part of an Assisted Reproductive Technology (ART) are tested for this specific monogenic disorder. Only unaffected or carrier embryos are transferred to have a disease-free child. This can also be combined with PGT-A to further improve success rates.
Six internationally accreditted, state-of-the-art hospitals and laboratories, committed to supporting you live your highest quality life, through the provision of leading edge, ethical healthcare solutions.